Cervical Cancer

New HPV-DNA Test To Screen Women In Developing Countries For Cervical Precancerous Disease Has 90% Success Rate
Results of a study to determine the accuracy of a new rapid screening test for HPV (human papillomavirus), created specifically for use in the developing world, have shown it to be 90% accurate in detecting precancerous cervical disease when tested on a group of women in Shanxi province, eastern China.

Helix Receives Approval To Open Sites In Germany For Its Ongoing Clinical Trial With Topical Interferon Alpha-2b In Patients With Ano-Genital Warts
Helix BioPharma announced that it has received the necessary regulatory approvals to open clinical sites in Germany to expand upon its clinical trial with Topical Interferon Alpha-2b in patients with ano-genital warts, which is presently underway in Sweden. "We are pleased to have received approval to open these additional clinical sites," said John Docherty, President of Helix BioPharma.

First Published Study Of New HPV Test For Developing Countries Shows High Accuracy In Predicting Cervical Disease
A new HPV test developed by QIAGEN specifically for use in regions of the world with scarce resources is "substantially" more accurate in identifying women with cervical disease than the current methods (Pap testing and visual inspection) in these countries.

Cervical Cancer Vaccines Could Be Cost-Effective For Developing Countries, Researchers Say
Cervical cancer vaccines from Merck and GlaxoSmithKline could be cost-effective if subsidies or new prices are created so developing countries can afford them, researchers said Thursday at the World Cancer Congress in Geneva, Reuters reports.

Study Of Cervical Cancer Survivors Suggests Hormones' Role In Sexuality Is Limited
Most long-term cervical cancer survivors report they have satisfying sex lives following surgical intervention, according to a recent study that challenges public perceptions of the role hormones play in sexual activity. The University of Southern California-Yale University study is significant because researchers documented the sexual experiences of women who presumably had no hormonally-motivated sexual behavior or interest.

Study Of Cervical Cancer Survivors Suggests Hormones' Role In Sexuality Is Limited
Most long-term cervical cancer survivors report they have satisfying sex lives following surgical intervention, according to a recent study that challenges public perceptions of the role hormones play in sexual activity. The University of Southern California-Yale University study is significant because researchers documented the sexual experiences of women who presumably had no hormonally-motivated sexual behavior or interest.

Cross-Protective Efficacy And Prevention Of Precancerous Vaginal Lesions Added To Gardasil(R) I Product Information
The product information of the four-type (6,11,16,18) human papillomavirus (HPV) vaccine Gardasil® has been updated to include cross-protective efficacy in preventing precancerous cervical lesions (CIN2/3 and AISiii) due to additional cancercausing HPV types related to HPV type 16.1 Statistically significant efficacy against disease was demonstrated against HPV 31 which is the second most common HPV type in Europe in causing precancerous cervical lesions, after type 16.

First Published Study Of New HPV Test For Developing Countries Shows High Accuracy In Predicting Cervical Disease
A new HPV test developed by QIAGEN specifically for use in regions of the world with scarce resources is "substantially" more accurate in identifying women with cervical disease than the current methods (Pap testing and visual inspection) in these countries.

MRI Assessment Of Tumour Spread And Response For Image Guided Cervical Cancer Brachytherapy
The treatment of choice for patients with locally advanced cervix cancer is a combination of external beam radiation therapy (EBRT), concomitant chemotherapy and brachytherapy (BT). An image guided approach (IGBT) using magnetic resonance imaging (MRI) is becoming state of the art for the BT component of this treatment . It increases the probability of cure and decreases side effects, due to dose escalation and organ sparing.

Study Of Cervical Cancer Survivors Suggests Hormones' Role In Sexuality Is Limited
Most long-term cervical cancer survivors report they have satisfying sex lives following surgical intervention, according to a recent study that challenges public perceptions of the role hormones play in sexual activity. The University of Southern California-Yale University study is significant because researchers documented the sexual experiences of women who presumably had no hormonally-motivated sexual behavior or interest.

HPV Vaccine - Is The Right Information Reaching The Right People?
New research released at the Royal College of Obstetricians and Gynaecologists (RCOG) 7th International Scientific Meeting in Montreal, has investigated awareness of the HPV vaccination programme amongst women including availability, effectiveness and whether they would recommend it to others. HPV is responsible for 70% of all cervical cancers. In the UK there are around 2800 new cases of cervical cancer each year and 1000 deaths.

Study Of Cervical Cancer Survivors Suggests Hormones' Role In Sexuality Is Limited
Most long-term cervical cancer survivors report they have satisfying sex lives following surgical intervention, according to a recent study that challenges public perceptions of the role hormones play in sexual activity. The University of Southern California-Yale University study is significant because researchers documented the sexual experiences of women who presumably had no hormonally-motivated sexual behavior or interest.

Blogs Comment On Addition Of HPV Vaccine To Immigration Rules; Forced Intercourse; Ab-Only Ed; HHS Rule; Palin
The following is a summary of selected women's health-related blog entries.~ "Immigration authorities Add Gardasil to List of Required Vaccines," Feministing: The U.S. Citizenship and Immigration Services on Monday

HPV Vaccine Deemed Safe Despite Higher Anaphylaxis Rates
According to a study published in CMAJ, young women who had human papillomavirus (HPV) vaccination were found to be five to twenty times more likely to have anaphylaxis than women identified in comparable school-based vaccination programs. Researchers, however, also considered the overall rates of anaphylaxis to be low with no serious lasting effects.

FDA Expands Use Of HPV Vaccine Gardasil For Vaginal, Vulvar Cancer Prevention
FDA on Friday approved expanding the use of Merck's human papillomavirus vaccine Gardasil to protect against cancers of the vagina and vulva, the AP/MSNBC.com reports (AP/MSNBC.com, 9/12). According to an FDA

Nebraska Women Benefit From Efforts To Close Gaps In Cancer Screening
A decade-long Nebraska study that showed disparities in breast and cervical cancer screenings could have spurred changes that raised the percentage of women screened in the state. "Disparities in screening between racial and ethnic groups, even in a homogeneous state such as Nebraska, are a problem and by digging into some of the differences we were able to have an impact on breast and cervical cancer screening," said lead study author Shingairai Feresu, Ph.D.

Cervical Cancer Vaccines Could Be Cost-Effective For Developing Countries, Researchers Say
Cervical cancer vaccines from Merck and GlaxoSmithKline could be cost-effective if subsidies or new prices are created so developing countries can afford them, researchers said Thursday at the World Cancer Congress in Geneva, Reuters reports.

HPV Vaccine Gardasil Might Not Be Cost-Effective For Adult Women, NEJM Study Says
Vaccinating young teens to prevent cervical cancer might be cost-effective, but a new study questions the cost-effectiveness of vaccinating older teenagers and women in their 20s, the Wall Street Journal reports. The study, conducted by researchers at the

Los Angeles Times Examines Some Parents', Doctors' Reservations About HPV Vaccine Gardasil
The Los Angeles Times on Monday examined the "serious reservations" some doctors and parents have about providing Merck's human papillomavirus vaccine Gardasil, which prevents transmission of strains of HPV that can cause cervical cancer, to young girls. According to data from Merck, about eight million girls and women in the U.S.

HPV Vaccine Gardasil Might Not Be Cost-Effective For Adult Women, NEJM Study Says
Vaccinating young teens to prevent cervical cancer might be cost-effective, but a new study questions the cost-effectiveness of vaccinating older teenagers and women in their 20s, the Wall Street Journal reports. The study, conducted by researchers at the

New York Times Examines Development, Advertising Of HPV Vaccines
In the last two years, cervical cancer has gone from an "obscure killer confined mostly to developing countries" to the "West's disease of the moment" through the "lightning-fast" transition of new human papillomavirus vaccines from development to "must-have injection[s]" in the U.S. and Europe, the New York Times reports.

Advanced Laparoscopic Techniques And The Use Of Harmonic(R) Technology In Gynecologic Surgery
Join surgeons, Dr. Roger Ferland and Dr. Lori Warren, for a free one-hour live webcast highlighting the use of minimally invasive techniques in gynecologic surgery. The doctors will focus on the patient benefits of two approaches, Total Laparoscopic Hysterectomy and Laparoscopic Supracervical Hysterectomy.

Cervical Cancer Prevention In U.S. Should Focus On Vaccinating Adolescent Girls And Revising Screening Policies
The cost-effectiveness of vaccination in the United States against human papillomavirus (HPV), a sexually-transmitted virus that causes cervical cancer, will be optimized by achieving universal vaccine coverage in young adolescent girls, by targeting initial "catch-up" efforts to vaccinate women

Controlling Cervical Cancer In The Developing World - Recent Advances Explained
Recent advances in cervical cancer prevention offer new hope for controlling the disease in developing countries, where 80% of cases occur.

HPV Vaccine Deemed Safe Despite Higher Anaphylaxis Rates
According to a study published in CMAJ, young women who had human papillomavirus (HPV) vaccination were found to be five to twenty times more likely to have anaphylaxis than women identified in comparable school-based vaccination programs. Researchers, however, also considered the overall rates of anaphylaxis to be low with no serious lasting effects.

Scientists Who Linked HPV With Cervical Cancer Win 20th Annual Warren Alpert Foundation Prize
Two scientists who discovered that specific types of human papillomavirus, or HPV, cause cancer of the cervix were announced as winners of the 20th annual Warren Alpert Foundation Scientific Prize. The Foundation recognizes Harald zur Hausen, Professor Emeritus, and Lutz Gissmann, Professor-both at the German Cancer Research Center in Heidelberg-for work in cloning and characterizing the most prevalent virus types in cervical cancer, HPV 16 and HPV 18.

New York Times Examines Development, Advertising Of HPV Vaccines
In the last two years, cervical cancer has gone from an "obscure killer confined mostly to developing countries" to the "West's disease of the moment" through the "lightning-fast" transition of new human papillomavirus vaccines from development to "must-have injection[s]" in the U.S. and Europe, the New York Times reports.

HPV Vaccine Gardasil Might Not Be Cost-Effective For Adult Women, NEJM Study Says
Vaccinating young teens to prevent cervical cancer might be cost-effective, but a new study questions the cost-effectiveness of vaccinating older teenagers and women in their 20s, the Wall Street Journal reports. The study, conducted by researchers at the

Audit Finds Reported Cervical Cancer Cases In Maryland Deliberately Altered In State Database
The number of reported cervical cancer cases in Maryland was deliberately overreported in a state database that records the number of cancer cases statewide, according to a recent audit conducted by the Department of Legislative Services, the

Cervical Cancer Vaccines Could Be Cost-Effective For Developing Countries, Researchers Say
Cervical cancer vaccines from Merck and GlaxoSmithKline could be cost-effective if subsidies or new prices are created so developing countries can afford them, researchers said Thursday at the World Cancer Congress in Geneva, Reuters reports.